Bortezomib-Based Therapy, without Stem Cell Transplantation, for Newly Diagnosed Multiple Myeloma Patients with t(4;14)

被引:0
|
作者
Reece, Donna E. [1 ]
Rodriguez, Giovanni Piza [1 ]
Belch, Andrew [2 ]
Szwajcer, David [3 ]
Pantoja, Mariela [1 ]
Kovacs, Michael [4 ]
Shustik, Chaim [5 ]
Bahlis, Nizar J. [6 ]
White, Darrell J. [7 ]
Chen, Christine [1 ]
Kukreti, Vishal [1 ]
Anglin, Peter [1 ]
Stewart, A. Keith [8 ]
Trudel, Suzanne [1 ]
机构
[1] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M4X 1K9, Canada
[2] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[3] CancerCare Manitoba, Hematol, Winnipeg, MB, Canada
[4] London Hlth Sci Ctr, London, ON, Canada
[5] Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada
[6] Univ Calgary, Dept Hematol, Calgary, AB, Canada
[7] Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada
[8] Mayo Clin Scottsdale, Scottsdale, AZ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1485 / 1486
页数:2
相关论文
共 50 条
  • [1] Bortezomib-Based Therapy without Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma Patients with t(4;14): A Canadian National Trial
    Reece, Donna E.
    Rodriguez, Giovanni Piza
    Szwajcer, David
    Minuk, Leonard A.
    Pantoja, Mariela
    Belch, Andrew
    Shustik, Chaim
    Stakiw, Julie
    White, Darrell J.
    Chen, Christine
    Kukreti, Vishal
    Tiedemann, Rodger E.
    Sebag, Michael
    Jenkins, Gayle
    Bahlis, Nizar J.
    Le, Lisa W.
    Trudel, Suzanne
    BLOOD, 2011, 118 (21) : 1704 - 1704
  • [2] Prospective Canadian Trial In Newly Diagnosed Multiple Myeloma Patients with t(4;14): Bortezomib-Based Therapy without ASCT
    Reece, Donna E.
    Rodriguez, Giovanni Piza
    Belch, Andrew
    Szwajcer, David
    Kovacs, Michael J.
    Shustik, Chaim
    Bahlis, Nizar J.
    White, Darrell J.
    Pantoja, Mariela
    Chen, Christine
    Kukreti, Vishal
    Anglin, Peter
    Trudel, Suzanne
    BLOOD, 2010, 116 (21) : 822 - 822
  • [3] Bortezomib-based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data
    Sandecka, Viera
    Pour, Ludek
    Spicka, Ivan
    Minarik, Jiri
    Radocha, Jakub
    Jelinek, Tomas
    Heindorfer, Adriana
    Pavlicek, Petr
    Sykora, Michal
    Jungova, Alexandra
    Kessler, Petr
    Wrobel, Marek
    Starostka, David
    Ullrychova, Jana
    Stejskal, Lukas
    Stork, Martin
    Straub, Jan
    Pika, Tomas
    Brozova, Lucie
    Sevcikova, Sabina
    Maisnar, Vladimir
    Hajek, Roman
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (04) : 466 - 474
  • [4] Bortezomib-Based Triplet Therapy As First Line Treatment in Newly Diagnosed Multiple Myeloma Patients in Peru
    Vasquez, Jule F.
    Cordova, Naty Lopez
    Castillo, Claudia
    Saavedra, Alexandra
    Calle, Cindy
    Chavez, Lourdes Isabel Lopez
    Alcarraz, Cindy Elizabeth
    Rios, Pedro Eduardo Lovato
    Matuk, Alexandra La Torre
    Laboriano, Jorge
    Vilcarano, Abner
    Tokumura, Carmen
    Quintana, Shirley
    Samanez-Figari, Cesar
    Vidaurre, Tatiana
    BLOOD, 2024, 144 : 6997 - 6998
  • [5] Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving bortezomib-based therapy for multiple myeloma
    Zhou, Xin
    Wang, Jing
    Xia, Jun
    Cheng, Feng
    Mao, Jingjue
    Zhu, Jianwei
    Guo, Hongfeng
    CANCER BIOMARKERS, 2018, 22 (01) : 43 - 48
  • [6] Treatment of newly diagnosed myeloma: Bortezomib-based triplet
    Rajan, Archana M.
    Rajkumar, S. Vincent
    SEMINARS IN ONCOLOGY, 2016, 43 (06) : 700 - 702
  • [7] An Economic Evaluation of Bortezomib-Based Induction Therapy in Double Transplant Protocols for Newly Diagnosed Multiple Myeloma Patients
    Wang, Si-Tien
    Duh, Mei Sheng
    Huang, Hui
    White, Leigh Ann
    Chang, Eva
    Esseltine, Dixie-Lee
    Marantz, Jing L.
    BLOOD, 2008, 112 (11) : 831 - 832
  • [8] Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma
    Brioli, Annamaria
    Zannetti, Beatrice Anna
    Zamagni, Elena
    Tacchetti, Paola
    Pantani, Lucia
    Mancuso, Katia
    Pezzi, Annalisa
    Rocchi, Serena
    Cavo, Michele
    HAEMATOLOGICA, 2014, 99 (11)
  • [9] Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving bortezomib-based therapy for multiple myeloma
    Zhou, Xin
    Wang, Jing
    Xia, Jun
    Cheng, Feng
    Mao, Jingjue
    Zhu, Jianwei
    Guo, Hongfeng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S5 - S5
  • [10] Combined immune score predicts the prognosis of newly diagnosed multiple myeloma patients in the bortezomib-based therapy era
    Wei, Min
    Guo, Honggang
    Liu, Siwei
    Xu, Fangfang
    Zhang, Yin
    Shi, Jie
    Xu, Zhiwei
    Chen, Yuqing
    MEDICINE, 2021, 100 (41) : E27521